An Huazhang, Xu Hongmei, Zhang Minghui, Zhou Jun, Feng Tao, Qian Cheng, Qi Runzi, Cao Xuetao
Institute of Immunology, Second Military Medical University, Shanghai, People's Republic of China.
Blood. 2005 Jun 15;105(12):4685-92. doi: 10.1182/blood-2005-01-0191. Epub 2005 Feb 8.
Src homology 2 (SH2) domain-containing inositol-5-phosphatase 1 (SHIP1) plays important roles in negatively regulating the activation of immune cells primarily via the phosphoinositide 3-kinase (PI-3K) pathway by catalyzing the PI-3K product PtdIns-3,4,5P3 (phosphatidylinositol-3,4,5-triphosphate) into PtdIns-3,4P2. However, the role of SHIP1 in Toll-like receptor 4 (TLR4)-mediated lipopolysaccharide (LPS) response remains unclear. Here we demonstrate that SHIP1 negatively regulates LPS-induced inflammatory response via both phosphatase activity-dependent and -independent mechanisms in macrophages. SHIP1 becomes tyrosine phosphorylated and up-regulated upon LPS stimulation in RAW264.7 macrophages. SHIP1-specific RNA-interfering and SHIP1 overexpression experiments demonstrate that SHIP1 inhibits LPS-induced tumor necrosis factor alpha (TNF-alpha) and interleukin 6 (IL-6) production by negatively regulating the LPS-induced combination between TLR4 and myeloid differentiation factor 88 (MyD88); activation of Ras (p21(ras) protein), PI-3K, extracellular signal-regulated kinase 1/2 (ERK1/2), p38, and c-Jun NH2-terminal kinase (JNK); and degradation of IkappaB-alpha. SHIP1 also significantly inhibits LPS-induced mitogen-activated protein kinase (MAPK) activation in TLR4-reconstitited COS7 cells. Although SHIP1-mediated inhibition of PI-3K is dependent on its phosphatase activity, phosphatase activity-disrupted mutant SHIP1 remains inhibitory to LPS-induced TNF-alpha production. Neither disrupting phosphatase activity nor using the PI-3K pathway inhibitor LY294002 or wortmannin could significantly block SHIP1-mediated inhibition of LPS-induced ERK1/2, p38, and JNK activation and TNF-alpha production, demonstrating that SHIP1 inhibits LPS-induced activation of MAPKs and cytokine production primarily by a phosphatase activity- and PI-3K-independent mechanism.
含Src同源2(SH2)结构域的肌醇-5-磷酸酶1(SHIP1)主要通过催化磷脂酰肌醇3激酶(PI-3K)产物PtdIns-3,4,5P3(磷脂酰肌醇-3,4,5-三磷酸)生成PtdIns-3,4P2,在负向调节免疫细胞激活中发挥重要作用。然而,SHIP1在Toll样受体4(TLR4)介导的脂多糖(LPS)反应中的作用仍不清楚。在此,我们证明SHIP1通过磷酸酶活性依赖性和非依赖性机制在巨噬细胞中负向调节LPS诱导的炎症反应。在RAW264.7巨噬细胞中,LPS刺激后SHIP1发生酪氨酸磷酸化并上调。SHIP1特异性RNA干扰和SHIP1过表达实验表明,SHIP1通过负向调节LPS诱导的TLR4与髓样分化因子88(MyD88)结合、Ras(p21(ras)蛋白)、PI-3K、细胞外信号调节激酶1/2(ERK1/2)、p38和c-Jun氨基末端激酶(JNK)的激活以及IkappaB-α的降解,抑制LPS诱导的肿瘤坏死因子α(TNF-α)和白细胞介素6(IL-6)产生。SHIP1还显著抑制LPS诱导的TLR4重组COS7细胞中丝裂原活化蛋白激酶(MAPK)的激活。虽然SHIP1介导的对PI-3K的抑制依赖于其磷酸酶活性,但磷酸酶活性破坏的SHIP1突变体对LPS诱导的TNF-α产生仍具有抑制作用。破坏磷酸酶活性或使用PI-3K途径抑制剂LY294002或渥曼青霉素均不能显著阻断SHIP1介导的对LPS诱导的ERK1/2、p38和JNK激活以及TNF-α产生的抑制作用,表明SHIP1主要通过磷酸酶活性和PI-3K非依赖性机制抑制LPS诱导的MAPK激活和细胞因子产生。